ADS Clinical Poster Session — ASN Events
1:30PM - 2:30PM
Exhibition

Posters remain on display throughout the meeting

A comparison of antenatal characteristics of women with gestational diabetes according to ethnic background (#251)

1:30 PM
Sarah Abdo

Overall diet quality score and type 2 diabetes (#252)

1:30 PM
Amani A Alhazmi

ARFS items and type 2 diabetes in Australian women (#253)

1:30 PM
Amani A Alhazmi

Are clinical trial participants different from the general diabetes population? Does it matter? (#254)

1:30 PM
Belinda Brooks

Sexual dysfunction in adults with diabetes: Results from Diabetes MILES-Australia (#255)

1:30 PM
Jessica L Browne

The needs, concerns, and characteristics of young Australian adults with type 2 diabetes (#256)

1:30 PM
Jessica L Browne

Emotional well-being and social and economic disadvantage in severely obese people with type 2 diabetes: Results from Diabetes MILES – Australia (#257)

1:30 PM
Jessica L Browne

The effects of commencing insulin pump therapy on glycaemic parameters in adult patients with type 1 diabetes – a CGMS study (#258)

1:30 PM
Neale Cohen

Liraglutide achieves HbA1c targets more often than sitagliptin or exenatide when added to metformin in patients with type 2 diabetes and a baseline HbA1c <8.0% (#259)

1:30 PM
Stephen Colagiuri

Lower Rates in Overall and Nocturnal Hypoglycemia of Insulin Degludec vs. Insulin Glargine with Treatment Intensification in T2DM in Moderately Good Control (A1c 7.5–8.5%) at Baseline: A Meta-Analysis (#260)

1:30 PM
Stephen Colagiuri

Clinical Experience with Exenatide: Case series of patients switched from insulin therapy to exenatide. (#261)

1:30 PM
Bethany Crinall

Longitudinal Changes in Serum Lipid Profiles and Their Management in Representative Australian Patients with Type 2 Diabetes: The Fremantle Diabetes Study (#262)

1:30 PM
Timothy ME Davis

Frequency of hand and shoulder symptoms in T1diabetes (#263)

1:30 PM
Peter Davoren

The GLP-1 Receptor Agonist Liraglutide Attenuates Atherosclerotic Lesion Development and Potentially Enhances Plaque Stability in an ApoE-/- Mouse Model (#264)

1:30 PM
Anthony E Dear

Does Diabetes Affect The Outcomes of Acute Pancreatitis? (#265)

1:30 PM
Barbara Depczynski

Fusion pore dynamics of insulin granules in intact islets of db/db mice (#266)

1:30 PM
Oanh H. Do

Glycemic Control In Adolescents (#267)

1:30 PM
Danijela Dravec

Glucose metabolism following stroke in people without diabetes (#268)

1:30 PM
Elif Ekinci

Review of Patients with Diabetic Ketoacidosis Admitted to General Physician Care in a Tertiary Hospital (#269)

1:30 PM
Richard Gauci

Type 2 diabetes mellitus in the Southern Fleurieu area: progression from diagnosis to commencement of insulin therapy (#270)

1:30 PM
Elizabeth Gebler-Hughes

Economic Benefit of Combining Vildagliptin with Insulin (#271)

1:30 PM
Dan L Harmelin

A case-report of diabetic myonecrosis in an Indigenous male from the Torres Strait Islands (#272)

1:30 PM
Fahid Hashem

An audit of psychological well-being in adults with type 1 diabetes attending tertiary diabetes clinics in Melbourne (#273)

1:30 PM
Christel Hendrieckx

Prevalence of self-reported severe hypoglycaemia in adults with type 1 diabetes attending tertiary diabetes clinics in Melbourne (#274)

1:30 PM
Christel Hendrieckx

How achievable is target HbA1c in insulin-treated type 2 diabetes (T2DM)? A multicentre study of 2025 patients from 8 specialist endocrine practices, including relationship of control to treatment centre and pattern of insulin administration (#275)

1:30 PM
David M Hoffman

Subjective wellbeing among adults with diabetes: Results from Diabetes MILES – Australia (#276)

1:30 PM
Elizabeth Holmes-Truscott

Haemoglobin age levels in type 1 diabetes patients are increased and correlate with vascular inflammation (#277)

1:30 PM
Andrzej S Januszewski

Plasma disappearance of inulin as a marker of glomerular filtration rate in type 2 diabetes (#278)

1:30 PM
George Jerums

Dietary AGE restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction. A systematic review. (#279)

1:30 PM
Nicole J Kellow

Diabetes care provision: Barriers, enablers and service needs of young adults with type 1 diabetes (#280)

1:30 PM
Katherine Kibbey

Risk factors for amputation in diabetes-related foot wounds treated by a multidisciplinary team. (#281)

1:30 PM
Mervyn Kyi

Is simulation training effective in increasing clinicians’ confidence in diabetic foot ulcer management?  The Foot Ulcer Simulation Training Project (#282)

1:30 PM
Peter A Lazzarini

New-Onset Diabetes Following Liver Transplant: Diabetes Treatment and Long Term Diabetic Complications (#283)

1:30 PM
Angela ST Lee

Relationship between serum aldosterone levels and urinary sodium excretion in patients with diabetes in the presence and absence of renin angiotensin aldosterone blockade (#284)

1:30 PM
Renata Libianto

In patients attending the diabetes antenatal clinic, glucose capillary-venous difference is not affected by prandial status (#285)

1:30 PM
Helen Lunt

Diabetic Foot Osteomyelitis (DFO) from a High Risk Foot Clinic in Saudi Arabia. A  Descriptive Study (#286)

1:30 PM
Matthew J Malone

The impact of professional roles and organisation of care on the interactional determinants of collaboration for health professionals involved in the initiation of insulin  (#287)

1:30 PM
Jo-Anne E Manski-Nankervis

Impact of Body Composition on the Accurate Assessment of Kidney Function in Indigenous Australians: the eGFR Study (#288)

1:30 PM
Louise Maple-Brown

Identifying risk factors for hypoglycaemic episodes in hospital inpatients. (#289)

1:30 PM
Natalie Marijanovic

Brittle Glycaemic Control in Type 1 Diabetes – A Management Dilemma (#290)

1:30 PM
Anish Menon

Simple population health management can result in a 27% increase in the number of people with optimal control of their Diabetes in Australia (#291)

1:30 PM
Chrys Michaelides

Why are patients with FBGL  > 7 mmol and RBGL >/==11.1 mmol remaining undiagnosed based on pathology data in 2011 and what can be done to increase awareness? (#292)

1:30 PM
Chrys Michaelides

The Effect of Insulin Degludec on Glycemic Control and Nocturnal Hypoglycemia Compared with Insulin Glargine: A 1-year Randomized Trial in Insulin-naïve People with Type 2 Diabetes (#293)

1:30 PM
John Miller

Impact Of Smoking On Impaired Insulin Secretion In A Japanese Population: The Saku Central Hospital Health Dock Center Study (#294)

1:30 PM
Akiko Morimoto

Saxagliptin (SAXA) effectively reduces HbA1c and is well tolerated when added to a combination of metformin (MET) and sulphonylurea (SU) (#295)

1:30 PM
Robert G Moses

Perioperative diabetes audit identifies inconsistent practice and suboptimal glycaemia (#296)

1:30 PM
Natalie Nanayakkara

Clinical competencies for clinicians working in diabetes related foot ulcer management: standardising care. (#297)

1:30 PM
Rajna Ogrin

Audit of glycaemic control and management in patients with diabetes in a cardiac unit (#298)

1:30 PM
M.L. Ong

Safety of dapagliflozin in clinical trials for T2DM (#299)

1:30 PM
Shamik Parikh

Durability of dapagliflozin treatment response in patients with T2DM: 2-year results (#300)

1:30 PM
Shamik Parikh

Patient Factors Predicting the Success or Failure of Sitagliptin Therapy in Type 2 Diabetes Mellitus (#301)

1:30 PM
Faseeha C Peer

Evaluation of a weight based, fixed-rate insulin regime in adults with diabetic ketoacidosis (#302)

1:30 PM
Gerry Fegan

Comparison of vildagliptin with placebo in a 24-week study of 221 patients with type 2 diabetes and severe renal impairment (eGFR<30) (#303)

1:30 PM
Joseph Proietto

Doubling of diabetes prevalence in hospital inpatients from 1996 - 2012 (#304)

1:30 PM
Nicholas Russell

Effect Of Twice Daily Exenatide In Combination With Insulin In Patients With Type 2 Diabetes (#305)

1:30 PM
Vishnumurthy Sannarangappa

Audit of outcomes of midwife-led gestational diabetes clinic (#306)

1:30 PM
Nandini Shankara - Narayana

Nocturnal Dipping of Mean Arterial Blood (MAP) Pressure is Related to Sodium Intake in Type 2 Diabetes and Abolished by morning angiotensin II receptor blockade (ARB) (#307)

1:30 PM
Anita Singh

Does the shortage of diabetes specialists in regional and rural Australia matter? Results from Diabetes MILES - Australia (#308)

1:30 PM
Timothy C Skinner

Safety & efficacy of biphasic insulin as part in people with type 2 diabetes (T2D) switched from a basal-bolus regimen: results from the A1chieve study (#309)

1:30 PM
M V Srishyla

Pre-existing diabetes in pregnancy:  Comparison between type 1 and type 2 diabetes: (#310)

1:30 PM
AJSP Himali N Suwandarathne

Increased Maternal Age and Primiparity of Women with Gestational Diabetes: Implications for Treatment and Workload (#311)

1:30 PM
Arianne Sweeting

Severe hypertriglyceridaemia in type 2 diabetes mellitus (#312)

1:30 PM
Alice Tang

Impact of soybean products intake on incidents of type 2 diabetes mellitus in a japanese population: the saku central hospital health dock center study (#313)

1:30 PM
Yukako Tatsumi

Effect of using standardised Queensland statewide Diabetes ketoacidosis (DKA) management protocol – An audit of 71 DKA admissions at the Townsville hospital (#314)

1:30 PM
Moe Thuzar

Hypoglycemia In Inpatients With Diabetes On Nasogastric Feeding (#315)

1:30 PM
Sally Vindedzis

Sustained improvement in NEFA suppression during IVGTT 3 years after islet- transplantation. (#318)

1:30 PM
Glenn Ward

Body mass index correlates with ischemic heart disease and albuminuria in long-standing type 2 diabetes (#319)

1:30 PM
John M Wentworth

Urine metabolomic profiling of experimental hyperglycaemia – towards an improved test for diabetic nephropathy (#320)

1:30 PM
John M Wentworth

Baseline determinants of Exenatide success or failure in Type 2 Diabetes (#321)

1:30 PM
Jennifer Woo

High rates of Gestational Diabetes in women who take antipsychotic medication during pregnancy (#322)

1:30 PM
Roisin Worsley

Diabetes after paediatric lung transplant (#323)

1:30 PM
Roisin Worsley

Fairfield Diabetes Clinic Communication Study (#324)

1:30 PM
Jenny Mrs wright

The use and acceptance of information technology in Australian diabetes care: implications for the future. (#325)

1:30 PM
Tim Middleton

Correlation of cyp2e1 expression elevation with extent of glycemic control in comparison to traditional clinical markers for diabetic nephropathy (#326)

1:30 PM
Christina G. Yap

Progression of Gestational Diabetes to Type 2 Diabetes amongst mothers from Cairns region in North Queensland who delivered in 2004 (1671)

1:30 PM
Nirjhar Nandi